A. Hatfield

Imatinib and altered bone and mineral metabolism.

S. Owen, A. Hatfield, L. Letvak, 2006, The New England journal of medicine.

International randomized study of interferon Vs STI571 (IRIS) 8-year follow up: Sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib

J. Radich, R. Larson, B. Druker, 2009 .

Treatment Interruptions and Non-Adherence with Imatinib Mesylate and Healthcare Costs A Retrospective Analysis among Managed Care Patients with Chronic Myelogenous Leukaemia

W. Feng, H. Henk, G. Goldberg, 2007 .

Report of an international expanded access program of imatinib in adults with Philadelphia chromosome positive leukemias.

J. Ford, I. Gathmann, R. Capdeville, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Thrombotic thrombocytopenic purpura associated with clopidogrel.

W R Bell, J. Moake, M. Feldman, 2000, The New England journal of medicine.

Physician Attitudes and Practice in Cancer Pain Management: A Survey From the Eastern Cooperative Oncology Group

J. V. Von Roenn, C. Cleeland, K. Pandya, 1993, Annals of Internal Medicine.

The effects of imatinib on pregnancy outcome.

G. Rosti, J. Cortes, J. Apperley, 2008, Blood.

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'

P. Pilot, S. Owen, A. Hatfield, 2007, Nature Medicine.

Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs

W. Feng, H. Henk, G. Goldberg, 2012, PharmacoEconomics.

Accidental and Intentional Overdose of Imatinib: a Report of Outcome and Side Effect of 46 Cases.

F. Guilhot, L. Roy, F. Millot, 2009 .

Compliance and persistency with imatinib.

H. Henk, G. Goldberg, J. Cortes, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.